![Glaukos Corporation logo](/logos/GKOS.webp)
Glaukos Corporation
NYSE:GKOS
Overview | Financials
Company Name | Glaukos Corporation |
Symbol | GKOS |
Currency | USD |
Price | 129.28 |
Market Cap | 7,104,000,640 |
Dividend Yield | 0% |
52-week-range | 59.22 - 136.605 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Thomas William Burns |
Website | https://www.glaukos.com |
An error occurred while fetching data.
About Glaukos Corporation
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD